Provider anticipation and experience of patient reaction when deprescribing guideline discordant inhaled corticosteroids

Provider anticipation and experience of patient reaction when deprescribing guideline discordant inhaled corticosteroids

Show other versions (1)

Introduction Despite evidence of possible patient harm and substantial costs, medication overuse is persistent. Patient reaction is one potential barrier to deprescribing, but little research has assessed this in specific instances of medication discontinuation. We sought to understand Veteran and p...

Full description

Bibliographic Details
Main Authors: Toral J. Parikh, Krysttel C. Stryczek, Chris Gillespie, George G. Sayre, Laura Feemster, Edmunds Udris, Barbara Majerczyk, Seppo T. Rinne, Renda Soylemez Wiener, David H. Au, Christian D. Helfrich, Adam Todd
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498097/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498097/?tool=EBI

Similar Items